Morgan E. Wagner

Biochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy”.

RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy

Science Advances(2023)10.1126/sciadv.adf4766

N/A

0.489DataRank · unranked

25 citations

Morgan E. Wagner, Richard Van, Monalisa Swain, Stephanie Mo, John Columbus +10 more

RASopathy Mutations Provide Functional Insight into the BRAF Cysteine-rich Domain and Demonstrate the Importance of Autoinhibition in BRAF Regulation

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.01.462773

N/A

0DataRank · unranked

1 citations

Elizabeth M. Terrell, Christine Insinna, Constance Agamasu, Morgan E. Wagner, Daniel A. Ritt +4 more

RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation

Molecular Cell(2022)10.1016/j.molcel.2022.10.016

N/A

0DataRank · unranked

44 citations

Elizabeth M. Terrell, Christine Insinna, Constance Agamasu, Morgan E. Wagner, Daniel A. Ritt +4 more

The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery

American Journal of Medical Genetics Part A(2022)10.1002/ajmg.a.62716

N/A

0DataRank · unranked

16 citations

Amy E. Roberts, Lisa Schill, Lisa Schoyer, Beth Stronach, Grégor Andelfinger +37 more

Ras-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.02.514888

N/A

0DataRank · unranked

1 citations

Morgan E. Wagner, Richard Van, Monalisa Swain, Madeline R. Allison, Alice Cheng +7 more